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ABSTRACT
Bacterial vaginosis (BV) is one of most common vaginal infections. However, its
diagnosis by classical methods reveals low specificity. Our goal was to evaluate the
accuracy diagnosis of 150 vaginal samples with research gold standard methods and
our Peptide Nucleic Acid (PNA) probes by Fluorescence in situ Hybridization (FISH)
methodology. Also, we described the first PNA-FISH methodology for BV diagnosis,
which provides results in approximately 3 h. The results showed a sensitivity of 84.6%
(95% confidence interval (CI), from 64.3 to 95.0%) and a specificity of 97.6% (95%
CI [92.6–99.4%]), demonstrating the higher specificity of the PNA-FISH method
and showing false positive results in BV diagnosis commonly obtained by the classical
methods. This methodology combines the specificity of PNA probes for Lactobacillus
species and G. vaginalis visualization and the calculation of the microscopic field
by Nugent score, allowing a trustful evaluation of the bacteria present in vaginal
microflora and avoiding the occurrence of misleading diagnostics. Therefore, the
PNA-FISH methodology represents a valuable alternative for BV diagnosis.
Subjects Microbiology, Molecular Biology, Epidemiology, Infectious Diseases, Women’s Health
Keywords Fluorescence in situ hybridization (FISH), Peptide Nucleic Acid Probe (PNA probe),
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INTRODUCTION
Bacterial vaginosis (BV) often exhibits high prevalence, high relapse rates and associated
complications, which renders this infection of global importance (Falagas, Betsi &
Athanasiou, 2007; Tibaldi et al., 2009). BV is associated with increased taxonomic richness
and diversity (Oakley et al., 2008) and is normally characterized by a decrease in vaginal
lactobacilli and a simultaneous increase in the anaerobes population (Tibaldi et al., 2009).
Therefore, vaginal bacterial communities differ dramatically between healthy patients
and patients with BV, where G. vaginalis is present in over 90% of BV cases (Verstraelen
& Swidsinski, 2013). The role of G. vaginalis is still controversial, since this bacterium
is also present in 10–40% of healthy women (Aroutcheva et al., 2001; Hickey & Forney,
2014; Silva et al., 2014); however, recent evidence suggests that the presence of G. vaginalis
biofilms, instead of dispersed cells, are in fact an indication of BV (Verstraelen & Swidsinski,
How to cite this article Machado et al. (2015), Diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in
situ hybridization method. PeerJ 3:e780; DOI 10.7717/peerj.780
2013). Furthermore, we recently demonstrated that G. vaginalis has a significantly higher
virulence potential than other 29 BV associated species, including a higher cytotoxicity and
biofilm formation ability (Alves et al., 2014). We also provided evidence that G. vaginalis
biofilms can establish synergistic relationships with other BV anaerobes (Machado,
Jefferson &Cerca, 2013), further highlighting its pivotal role on BV development.
The most frequently used method for BV diagnosis is the physician’s assessment
by the Amsel clinical criteria (Forsum, Halle´n & Larsson, 2005). This method is fairly
subjective and is based on the observation of the following symptoms: vaginal fluid
with pH above 4.5; positive “whiff test” (detection of fishy odor upon 10% potassium
hydrogen addition); presence of clue cells (vaginal epithelial cells covered by bacteria) on
microscopic examination of vaginal fluid; and homogeneous milky vaginal discharge. At
least three of the four symptoms described above must be present to establish a positive
BV diagnosis (Amsel et al., 1983). Despite the fact that the Amsel criteria does not require
intensive training, it is not the most appropriate method to diagnose BV, due to its low
specificity (Dickey, Nailor & Sobel, 2009).
Alternatively, laboratory diagnosis is based on the Nugent score analysis, a microscopic
method that quantifies three different bacteria morphotypes presented in the vaginal
smears (Nugent, Krohn & Hillier, 1991). These authors have created a Gram stain scoring
system based on the evaluation of the following morphotypes: large gram-positive rods
(Lactobacillus spp. morphotypes); small gram-variable rods (G. vaginalis morphotypes);
small gram-negative rods (Bacteroides spp. morphotypes); and curved gram-variable rods
(Mobiluncus spp. morphotypes). Each morphotype is quantified from 0 to 4 with regard
to the number of morphotypes observed in the microscopic fields of the Gram-stained
vaginal smear. The vaginal microflora is then classified in normal microflora (scores of 0
to 3) or as BV (scores of 7 to 10), based on the sum of each morphotype score (Livengood,
2009; Nugent, Krohn & Hillier, 1991). However, the evaluation of smears is also subjective
and user dependent (Sha et al., 2005). Furthermore, due to its low specificity, the Nugent
method also considers intermediate microflora whenever the final score is between 4 and 6.
Although both methodologies are easy and fast to perform, they do not provide a robust
diagnosis of BV. When combined, these standard tests have a sensitivity and specificity of
81 and 70% (Forsum, Halle´n & Larsson, 2005), respectively. To improve BV diagnosis,
several new molecular methodologies have been proposed, with fluorescence in situ
hybridization (FISH) being a very promising alternative. This technique combines the
simplicity of microscopic observation and the specificity of DNA/rRNA hybridization,
allowing the detection of selected bacterial species and morphologic visualization
(Juste´, Thomma& Lievens, 2008; Nath, 2000). Peptide Nucleic Acid (PNA) probes are used
instead of natural nucleic acids to improve FISH efficiency because they enable quicker
and more specific hybridization (Lefmann et al., 2006; Peleg et al., 2009; Wilson et al.,
2005). These types of probes, in which bases are linked by a neutral peptide backbone,
avoid the repulsion between the negatively charged phosphate backbone characteristics
of DNA/DNA hybridization (Stender et al., 2002). Since PNA is a synthetic molecule,
probes are also resistant against cytoplasmic enzymes such as nucleases and proteases
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(Amann & Fuchs, 2008). In addition, the hybridization step can be performed efficiently
under low salt concentrations, which promotes the destabilization of rRNA secondary
structures and consequently improves the access to target sequences (Almeida et al., 2009;
Cerqueira et al., 2008). All these advantages have made PNA-FISH a new promising tool
for diagnosis and therapy-directing techniques, providing already a rapid and accurate
diagnosis of several microbial infections (Hartmann et al., 2005; Shepard et al., 2008;
Søgaard et al., 2007; Trnovsky et al., 2008).
We have previously developed a multiplex PNA-FISH method able to specifically
quantify in vitro Lactobacilli spp. and G. vaginalis adhered to HeLa cells (Machado et al.,
2013). To determine the feasibility of our novel PNA-FISH method as a diagnostic tool for
BV, we have blind-tested our multiplex methodology on vaginal samples from Portuguese
women and compared those results with the laboratory microscopic derived method using
the Nugent score.
MATERIAL & METHODS
Vaginal sample collection and preparation
A total of 200 vaginal fluid samples were obtained, after informed consent, as approved
by the Institutional Review Board (Subcomissa˜o de E´tica para as Cieˆncias da Vida e
Sau´de) of University of Minho (process SECVS 003/2013). The vaginal samples were
collected for Gram staining and FISH procedures, using the culture swab transport
system (VWR, CE0344, Italy). The extraction procedure from transport media was
elaborated in accordance with Money’s guidelines to avoid misleading in the Nugent
score analysis of the vaginal swabs (Money, 2005). These swabs were brushed against
the lateral vaginal wall to collect the vaginal fluid sample, placed into the culture swab
transport media and immediately stored at 4 ◦C. First, the vaginal samples were used for
Gram stain procedure, as described by Nugent, Krohn & Hillier (1991). Next, swabs were
immersed in 1 ml of phosphate buffer saline (PBS) and the remaining vaginal material
collected by centrifugation at 17,000 g during 5 min at room temperature. Afterwards, the
pellet was resuspended in 2 ml of saline solution (0.9%NaCl) and finally diluted 1:10 in
saline solution or PBS to eliminate possible contaminants that could interfere with FISH
procedures, as previously described (Machado et al., 2013).
Classification of vaginal smears according to Nugent score
Vaginal samples evaluation was performed using the Nugent criteria score (Nugent, Krohn
&Hillier, 1991). Briefly, Gram stained vaginal smears were examined under oil immersion
objective (1,000×magnification) and 10–15 microscopic fields were evaluated for each
sample. The composite score was grouped into three categories, scores 0–3 being normal,
4–6 being intermediate, and 7–10 being definite bacterial vaginosis. Finally, the smears that
showed scores between 0–3 and 7–10 were selected for further study, as normal (−) and
BV (+) samples, respectively. Meanwhile, the smears with a Nugent score of 4–6 or with
incomplete epidemiological data were rejected from our study.
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Fluorescent in situ hybridization
The 150 BV+ or BV− (as described above) vaginal samples were used on a blind
PNA-FISH test. For each sample, 20 µl of the final suspension were spread on glass slides.
The slides were air-dried prior to fixation. Next, the smears were immersed in 4% (wt/vol)
paraformaldehyde (Fisher Scientific, Leicestershire, United Kingdom) followed by 50%
(vol/vol) ethanol (Fisher Scientific, Leicestershire, United Kingdom) for 10 min at room
temperature on each solution. After the fixation step, the samples were covered with 20 µl
of hybridization solution containing 10% (wt/vol) dextran sulphate (Fisher Scientific,
United Kingdom), 10 mM NaCl (Sigma, Seelze, Germany), 30% (vol/vol) formamide
(Fisher Scientific, Leicestershire, United Kingdom), 0.1% (wt/vol) sodium pyrophosphate
(Fisher Scientific, Leicestershire, United Kingdom), 0.2% (wt/vol) polyvinylpyrrolidone
(Sigma, Seelze, Germany), 0.2% (wt/vol) ficoll (Sigma, Seelze, Germany), 5 mM disodium
EDTA (Sigma, Seelze, Germany), 0.1% (vol/vol) triton X-100 (Sigma, Seelze, Germany),
50 mM Tris-HCl (at pH 7.5; Sigma, Seelze, Germany) and 200 nM of each PNA probe
(Lactobacillus spp. PNA Probe: Lac663 probe, Alexa Fluor 488-ACATGGAGTTCCACT;
HPLC purified >90%; Gardnerella vaginalis PNA Probe: Gard162 probe, Alexa Fluor
594-CAGCATTACCACCCG; HPLC purified >90%). Subsequently, the smears were
covered with coverslips and incubated in moist chambers at the hybridization temperature
(60 ◦C) during 90 min. Next, the coverslips were removed and a washing step was
performed by immersing the slides in a pre-warmed washing solution for 30 min at
the same temperature of the hybridization step. This solution consisted of 5 mM Tris
base (Fisher Scientific, Leicestershire, United Kingdom), 15 mM NaCl (Sigma, Seelze,
Germany) and 0.1% (vol/vol) triton X-100 (at pH 10; Sigma, Seelze, Germany). Finally, the
glass slides were allowed to air dry.
Fluorescence microscopic visualization and bacterial
quantification
Prior to microscopy, one drop of non-fluorescent immersion oil (Merck, Darmstadt,
Germany) was added to either slides and covered with coverslips. Microscopic visualization
was performed using an Olympus BX51 (Olympus Optics Portugal SA, Lisboa, Portugal)
epifluorescence microscope equipped with a CCD camera (DP72; Olympus, Shinjuku,
Tokyo, Japan) and filters capable of detecting the two PNA probes (BP 470-490, FT500,
LP 516 sensitive to the Alexa Fluor 488 molecule attached to the Lac663 probe and BP
530-550, FT 570, LP 591 sensitive to the Alexa Fluor 594 molecule attached to the Gard162
probe).
In each experimental assay, a negative control was performed simultaneously, in which
all the steps described above were carried out, but where no probe was added in the
hybridization step. Finally, 20 random regions of each glass slide were photographed. All
images were acquired using Olympus CellB software using a total magnification of×1,000.
Statistical analysis
The data was analyzed to calculate sensitivity, specificity, accuracy, positive and negative
likelihood ratios (PLR and NLR, respectively) of the PNA-FISH methodology, with 95%
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Table 1 Characteristics of the population of study (n = 150). The samples classification as normal or
BV was performed according the Nugent score.
Variables Women with normal
flora (n= 124)
Women with BV
(n= 26)
Age (years) 30.2± 11.42 32.5± 9.7
With children (%)
No 68.5 50.0
Yes 27.4 50.0
Pregnant women (%) 4.0 0.0
Previously diagnosed with bacterial vaginosis (%) 16.9 38.5
Contraception (%)
No contraception 8.9 15.4
Pill 54.0 61.5
Condom 25.8 11.5
Other 12.1 15.4
Notes.
Data are mean± standard deviation or n (%).
confidence intervals (CI), using a clinical online statistical software (www.vassarstats.net/
clin1.html; accessed 2014) (Senthilkumar, 2006). The classic Nugent criteria score was used
as the diagnostic true.
RESULTS AND DISCUSSION
On this prospective study, 150 vaginal samples were used to compare BV diagnosis by
the classic Nugent criteria and our PNA-FISH methodology. As shown in Table 1, the
main characteristics of the sample population used to validate our method mirrors what
has been described in other main epidemiological studies, namely (1) the overall rate of
positive BV cases (17%) in the general population (Koumans et al., 2007; Li et al., 2014;
Jespers et al., 2014), (2) an association between previous BV infections and BV positive
diagnostic (Bilardi et al., 2013; Guedou et al., 2013), (3) a higher risk factor for women
using the pill instead of a condom (Bradshaw et al., 2013; Guedou et al., 2013), and (4) the
history of previous pregnancy being higher in women with BV (Africa, Nel & Stemmet,
2014;Mengistie et al., 2014).
As shown in Table 2, the PNA-FISH method was able to diagnose 121 from a total of 124
healthy cases and was capable of categorizing 22 positive cases from a total of 26 BV cases
when compared with the standard Nugent score. The PNA-FISH methodology was capable
of illustrating clear differences between healthy and BV samples, showing specific detection
of Lactobacillus spp. and G. vaginalis species directly in clinical samples. In fact, a typically
healthy sample and a BV sample exhibited a totally different vaginal microflora, such as
UM300 and UM235 samples, respectively, being clue cells, and G. vaginalis augmentation
was easily detected in the UM235 sample (see Fig. 1). However, some discrepancies were
also found between the two methodologies; specifically, in 7 vaginal samples. In fact,
4 vaginal samples were positive for BV by Gram staining but negative by PNA-FISH
evaluation, while the others 3 vaginal samples were negative for BV by Gram staining
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Figure 1 Fluorescence microscopy pictures of Lactobacillus spp., Gardnerella vaginalis and others bacteria species from a healthy (UM300) and
a BV (UM235) vaginal clinical samples by specific PNA probes (Lac663 and Gard162) associated with Alexa Fluor 488 and 594 fluorochromes
and DAPI staining, respectively. (A) Green filter; (B) red filter; (C) blue filter; (D) overlay of the three previous filters. As shown in the green filter
(A), UM300 (healthy) and UM235 (BV) samples showed the presence of Lactobacillus spp. species but only BV sample demonstrated an elevated G.
vaginalis concentration in the vaginal swabs (red filter (B)), which they proved to stablish clue cells by overground the vaginal epithelial cells in the
blue filter (C). Therefore, both vaginal swab samples exhibited a totally different vaginal microflora, as finally we may observe in the overlay of the
filters (D), being clue cells, and G. vaginalis augmentation was easily detected in the UM235 sample.
Table 2 Comparison between PNA-FISH method versus Gram staining using Nugent score criteria
for BV diagnosis.
PNA-FISH results Nugent results
BV+ BV+ Total
BV+ 22 3 25
BV− 4 121 125
Total 26 124 150
Statistical analysis of PNA-FISH method
Estimated value Lower limit Upper limit
Sensitivity 84.6% 64.3% 95.0%
Specificity 97.6% 92.6% 99.4%
Accuracy 95.3% 89.2% 98.3%
Positive likelihood 34.97 11.30 108.24
Negative likelihood 0.16 0.06 0.39
but positive by PNA-FISH evaluation. It is well known that conventional BV diagnosis
accuracy is highly dependent on the training and experience of the technician due to the
unspecific staining of the Gram method (Simoes et al., 2006), which might explain some of
the discrepant results observed.
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To better evaluate the diagnostic value of the proposed PNA-FISH approach, the
technique performance was assessed by determining the following parameters: specificity,
sensitivity, accuracy, PLR, NLR. Based on these results, an experimental specificity of
97.6% (95% CI [92.6–99.4%]) and sensitivity of 84.6% (95% CI [64.3–95.0%]) were
obtained for the BV diagnosis by our PNA-FISH method (Table 2). Therefore, a high
accuracy was also obtained for our PNA-FISH method; more exactly, a value of 95.3%
(95% CI [89.2–98.3%]).
Regarding the likelihood ratios, the PNA-FISH method evidenced a PLR of 34.97 and a
NLR of 0.16. So, the specificity and the NLR values show the test ability to correctly identify
as normal a person who does not have BV. Meanwhile, the low NLR obtained, in fact,
shows that the probability of having BV is much decreased (0.16) for a negative PNA-FISH
result. Moreover, our experimental specificity is revealed to be superior to Nugent’s Gram
stain system specificity (83%) (Schwebke et al., 1996). Therefore, our method was able to
correctly identify 97.6% of those patients previously classified with normal vaginal flora,
making PNA-FISH a trustful method to ensure a healthy diagnosis and avoiding false
positive results.
In opposition, the sensitivity and PLR values demonstrated a strong association between
a positive result for BV diagnostic and the probability of the patient indeed having BV.
In this case, the high PLR shows us the increase in probability of having BV (35×) if
the test result is positive. The sensitivity value was in fact lower than expected, taking in
consideration our previous in vitro experiments, where we have reached to a sensitivity
of 100% (95% CI, [81.5–100.0%]) (Machado et al., 2013). Despite the fact that the
experimental sensitivity (84.6%) was slight lower than the specificity of the Gram staining
by the Nugent score (89%) (Schwebke et al., 1996), it was nevertheless higher than the
Amsel criteria sensitivity (60%) determined by Gallo et al. (2011). It is important to
mention that other bacterial species, with similar Gram staining morphology, could be
at a high number in the samples, leading to an incorrect classification of BV according
to Nugent criteria. In fact, Verhelst and colleagues presented evidences that infers a lack
of accuracy in the interpretation of the results in Gram stain by the Nugent score in their
clinical results (Verhelst et al., 2005). Forsum and colleagues also found discrepancies in
scoring bacterial cell types when pleomorphic lactobacilli and other kinds of bacteria could
be regarded as G. vaginalis cells, leading to an incorrect BV diagnosis (Forsum et al., 2002;
Schwiertz et al., 2006). Also, it is important to mention that G. vaginalis may vary in size
and form, from round to more elongated, with no defined border to separate them from
the lactobacilli morphotypes (Forsum et al., 2002), thus illustrating again problems in the
accuracy of the smears interpretation. These facts suggest that the sensitivity value has
likely been underestimated.
Overall, despite the cost-effective nature of the Nugent score, the PNA-FISH appears to
be an accurate method for detecting BV from vaginal samples while maintaining a similar
complexity as the previous standard method.
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CONCLUSIONS
In conclusion, in this study we described the first PNA-FISH methodology applied for
BV diagnosis, and the parameters evaluated have proved its potential as a diagnostic tool.
The performance characteristics of this PNA-FISH method also suggest that it might be a
reliable alternative to the Amsel criteria and Gram stain under the Nugent score. Despite
that our sample size was somewhat small, the population at study was representative from
what has been described by many other epidemiological studies, therefore validating this
prospective study.
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